Alliances are going to help community oncology participate in things that, as individual practices, they don‘t have the opportunity to do, said Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
Alliances are going to help community oncology participate in things that, as individual practices, they don‘t have the opportunity to do, said Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
Transcript
How will alliances among practices affect the future of cancer care?
I think they’re essential for the future of cancer care because without alliances, you don’t have the scale and scope to really participate in all the things that are coming down the pike. Artificial intelligence is not cheap, it’s expensive. New technology is not cheap, it’s expensive. Payer contracting and employer contracting and that’s what a lot of us are really hoping in the future happens, that the employers who are the real payers, that we can have direct relationships with them. All of that requires size and scale and I think those alliances are going to help community oncology participate in things that, as individual practices, we just don‘t have the opportunity to do so.
It was really the theory behind the whole start of US Oncology, and the theory behind Florida Cancer [Specialists] in American Oncology and the theory behind the sort of blossoming OneOncology alliance that’s developing a little more formal, a little more structured, but is that size and scale can really help you in the technology world and in the payer world and in the developing [accountable care organization] and employer market world.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More